1. Home
  2. AXGN vs VIR Comparison

AXGN vs VIR Comparison

Compare AXGN & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXGN
  • VIR
  • Stock Information
  • Founded
  • AXGN N/A
  • VIR 2016
  • Country
  • AXGN United States
  • VIR United States
  • Employees
  • AXGN N/A
  • VIR N/A
  • Industry
  • AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • VIR Biotechnology: Pharmaceutical Preparations
  • Sector
  • AXGN Health Care
  • VIR Health Care
  • Exchange
  • AXGN Nasdaq
  • VIR Nasdaq
  • Market Cap
  • AXGN 887.3M
  • VIR 724.1M
  • IPO Year
  • AXGN N/A
  • VIR 2019
  • Fundamental
  • Price
  • AXGN $16.40
  • VIR $6.12
  • Analyst Decision
  • AXGN Strong Buy
  • VIR Strong Buy
  • Analyst Count
  • AXGN 6
  • VIR 7
  • Target Price
  • AXGN $24.17
  • VIR $33.57
  • AVG Volume (30 Days)
  • AXGN 456.8K
  • VIR 1.2M
  • Earning Date
  • AXGN 05-08-2025
  • VIR 05-05-2025
  • Dividend Yield
  • AXGN N/A
  • VIR N/A
  • EPS Growth
  • AXGN N/A
  • VIR N/A
  • EPS
  • AXGN N/A
  • VIR N/A
  • Revenue
  • AXGN $187,338,000.00
  • VIR $74,205,000.00
  • Revenue This Year
  • AXGN $18.10
  • VIR N/A
  • Revenue Next Year
  • AXGN $16.29
  • VIR $10.65
  • P/E Ratio
  • AXGN N/A
  • VIR N/A
  • Revenue Growth
  • AXGN 17.81
  • VIR N/A
  • 52 Week Low
  • AXGN $5.55
  • VIR $4.95
  • 52 Week High
  • AXGN $21.00
  • VIR $14.45
  • Technical
  • Relative Strength Index (RSI)
  • AXGN 47.98
  • VIR 48.06
  • Support Level
  • AXGN $14.80
  • VIR $5.85
  • Resistance Level
  • AXGN $15.80
  • VIR $6.30
  • Average True Range (ATR)
  • AXGN 0.97
  • VIR 0.43
  • MACD
  • AXGN 0.05
  • VIR 0.16
  • Stochastic Oscillator
  • AXGN 63.49
  • VIR 86.99

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: